Equities

Elicera Therapeutics AB

Elicera Therapeutics AB

Actions
  • Price (SEK)0.95
  • Today's Change0.01 / 1.06%
  • Shares traded422.20k
  • 1 Year change-74.04%
  • Beta--
Data delayed at least 15 minutes, as of Apr 26 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • ELIC:STO trading volume exceeds daily average by +95.66%
  • ELIC:STO price reached a new 52-week low of 0.998 at 10:21 BST
  • ELIC:STO price moved over -5.07% to 1.03

Key statistics

On Friday, Elicera Therapeutics AB (ELIC:STO) closed at 0.95, 5.56% above its 52-week low of 0.90, set on Apr 25, 2024.
52-week range
Today
0.90Apr 25 20247.24Nov 01 2023
Open0.94
High1.04
Low0.91
Bid0.95
Offer0.95
Previous close0.94
Average volume189.00k
Shares outstanding35.09m
Free float22.91m
P/E (TTM)--
Market cap33.34m SEK
EPS (TTM)-0.8289
SEK
Data delayed at least 15 minutes, as of Apr 26 2024 17:00 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.